AU2932889A - Creation of Inventions and Patents with Artificial Intelligence

AU2932889A – Detection of salmonella
– Google Patents

AU2932889A – Detection of salmonella
– Google Patents
Detection of salmonella

Info

Publication number
AU2932889A

AU2932889A
AU29328/89A
AU2932889A
AU2932889A
AU 2932889 A
AU2932889 A
AU 2932889A
AU 29328/89 A
AU29328/89 A
AU 29328/89A
AU 2932889 A
AU2932889 A
AU 2932889A
AU 2932889 A
AU2932889 A
AU 2932889A
Authority
AU
Australia
Prior art keywords
salmonella
rrna
probe
nucleic acid
probes
Prior art date
1987-12-01
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Abandoned

Application number
AU29328/89A
Inventor
David J. Lane
Kyriaki Parodos
Ayoub Rashtchian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

BP Corp North America Inc

Original Assignee
BP Corp North America Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1987-12-01
Filing date
1988-11-30
Publication date
1989-07-05

1988-11-30
Application filed by BP Corp North America Inc
filed
Critical
BP Corp North America Inc

1989-07-05
Publication of AU2932889A
publication
Critical
patent/AU2932889A/en

1992-01-23
Assigned to AMOCO CORPORATION
reassignment
AMOCO CORPORATION
Alteration of Name(s) of Applicant(s) under S113
Assignors: GENZYME CORPORATION

Status
Abandoned
legal-status
Critical
Current

Links

Espacenet

Global Dossier

Discuss

Classifications

C—CHEMISTRY; METALLURGY

C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING

C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions

C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids

C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes

C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms

C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria

C—CHEMISTRY; METALLURGY

C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING

C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions

C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids

C12Q1/6813—Hybridisation assays

Abstract

Nucleic acid fragments capable of hybridizing to rRNA of a Salmonella species and not capable of hybridizing to rRNA of Escherichia coli.

Description

DETECTION OF SALMONELLA
Background of the Invention
This invention relates to detecting bacteria belonging to the genus Salmonella. (The term “Salmonella/” as used herein, refers to the bacteria classified as such in Bergey’s Manual of Systematic Bacteriology, infra) . Detection of Salmonella bacteria is important in various medical and public health contexts. From the standpoint of human disease, Salmonella species are one of the most important bacteria. Salmonella bacteria can cause a variety of infections ranging from simple gastroenteritis to more severe illnesses.
According to a standard laboratory method, the presence of Salmonella in clinical specimens (e.g., stool) is detected by culturing an appropriately prepared sample on microbiological media under conditions favorable for growth of these organisms. The resulting colonies are examined for morphological and biochemical characteristics, a process that typically is started 48 hours after acquisition of the sample and takes’ several days to complete.
Taber et al,, U.S. Patent No. 4,689,295, discloses the use of DNA probes specific for Salmonella DNA to detect the presence of bacteria of the genus Salmonella in food. ohne et al. (1968), Biophysical Journal 8:
1104-1118, discuss one method for preparing probes to rRNA sequences.
Pace, (1971), Journal of Bacteriology 107: 543-547, and Campbell (1971) discuss the homology of

ribosomal ribonucleic acids from diverse bacterial species and a hybridization method for quantitating these homology levels.
Sogin, et al. (1972), Journal of Molecular Evolution 1: 173-184, discuss the theoretical and practical aspects of using primary structural characterization of different ribosomal RNA molecules for evaluating phylogenetic relationships.
Fox et al. (1977), International Journal of Q Systematic Bacteriology 27: 44-57, discuss the comparative cataloging (of 16S ribosomal RNAs) approach to prokaryotic systematics.
Kohne et al., (1983), Gen-Probe Patent Appl., (Ref.?) describe a strategy for obtaining nucleic acid 5 fragments for use as probes to ribosomal RNA molecules.
The present invention will be -better understood in light of the following definitions:
DNA – an abbreviation for deoxyribonucleic > . .acid, the type of nucleic acid containing deoxyribose as 0 the sugar component and considered to be the repository of hereditary charcteristics; i.e., the genetic material of which genes are composed.
RNA – an abbreviation for ribonucleic acid, the type of nucleic acid containing ribose as the sugar 5 component and which, most generally, is transcribed (copied) from DNA. RNA molecules may- serve informational (e.g., messenger RNA), catalytic (e.g. RNase P), or structural (e.g., ribosomal RNA, see below) cellular functions. 0 rRNA – Ribosomal RNA (rRNA) molecules are key elements of ribosomes, complex protein and RNA-containing “organelles” which, together with transfer RNAs, comprise the translation apparatus.

Ribosomes are of profound importance to all organisms because they serve as the only known means of translating genetic information into cellular proteins, the main structural and catalytic elements of life. A clear manifestation of this importance is the observation that all cells have ribosomes.
Ribosomes contain three distinct RNA molecules which, in E^ coli, are referred to as 5S, 16S and 23S rRNAs. These names historically are related to the size of the RNA molecules, as determined by sedimentation rate. However, they actually vary substantially in size between organisms. 5S, 16S, and 23S rRNA are commonly used as generic names for the homologous RNA molecules in any bacteria, and will be so used here. The evolutionary homologs of these three RNA molecules are present in the ribosomes of all organisms. In eukaryotes, the homologous RNAs are designated 5S, 18S, and 28S rRNA, respecively. Eukaryotes contain, in – addition, a fourth rRNA species named*5.8S* rRNA whose structural and, presumably, functional homolog is found at the 5′ end of bacterial 23S rRNA. Hybridization – the process by which, under defined reaction conditions, two partially or completely complementary nucleic acids are allowed to come together in an antiparallel fashion and form specific and stable hydrogen bonds. The stringency of a particular set of hybridization conditions is defined by the base composition of the probe/target duplex, as well as by the level and geometry of mispairing between the two nucleic acids. Stringency may also be governed by such reaction parameters as the concentration and type of ionic species present in the hybridization solution, the types and concentrations of denaturing agents present,

and/or the temperature of hybridization.
Probe(s) – synthetic or biologically produced nucleic acids (DNA or RNA) which, by design or selection, contain specific nucleotide sequences that allow them to hybridize, under defined stringencies, specifically (i.e., preferentially) to target nucleic acid sequences.
Target molecule – a nucleic acid molecule to which a particular probe is capable of preferentially hybridizing.
Target sequence – a nucleic acid sequence within the target molecules to which a particular probe is capable of preferentially hybridizing.
Salmonella-specific sequences – nucleotide sequences within a target molecule which exhibit significant sequence differences between Salmonella and non-SaImonel1a enteric bacteria.
Other definitions are given as their first use arises in tlie text.
Summary of the Invention The present invention features nucleic acid probes or probe sets consisting essentially of DNA or RNA sequences which are capable, under specific hybridizing conditions, of detecting the presence of ribosomal RNA (rRNA) molecules of Salmonella bacteria and are not capable, under the same conditions, of detecting the rRNA of non-Salmonella bacteria which may be present in the test sample. The present invention also features an assay system for the utilization of said probes, the format of which can enhance the aforementioned desirable behavior of the probes. The invention exhibits the following

enhanced performance capabilities: a) increased sensitivity; i.e., the ability to detect fewer Salmonella in any given sample than presently available methods, b) potentially significant cost reductions in probe production due to the use of chemically, rather than biologically, synthesized probes, and c) accurate identification of even biochemically unusual Salmonella, because of the rRNA sequence characterizations which provide the basis of such identification.
The use of Salmonella rRNA as target molecules provides a number of advantages, among them:
1) The rRNAs constitute a significant component of cellular mass. Although estimates of cellular riboso e content vary, actively growing
A Salmonella bacteria may contain upwards of 5.0 x 10
A ribosomes per cell, and therefore 5.0 x 10- copies of each of the rRNAs (present in a 1:1:1 stoichiσmetry in ribosomes). In contrast, most other potential cellular target molecules, genes or RNA transcripts thereof, are present in much lower abundance.
(2) The rRNAs (and the genes encoding them) appear not to be subject to lateral transfer between contemporary organisms. Thus, rRNA primary structure provides an organism-specific molecular target, rather than a gene-specific target as would likely be the case, for example, of a plasmid-borne gene or product thereof which may be subject to lateral transmission between contemporary organisms.
In addition to providing the advantages inherent in rRNA detection, above, the present invention provides probes to Salmonella rRNA target sequences

which are sufficiently similar in a significant number of Salmonella that one or a few probes can hybridize to the target region in those Salmonella, and are sufficiently different in most or all non-Salmonella rRNAs that, under some conditions where the probe(s) hybridize to Salmonella rRNAs, they are not capable of hybridizing, or hybridize very poorly, to most non-Salmonella rRNAs. These probe characteristics are defined as inclusivity and exclusivity, respectively. As described in detail below, the true situation is considerably more complex than simply defining a probe (or set of probes) which hybridize to all Salmonella and not non-Salmonella bacteria. A number of probes are described which specifically hybridize to certain interesting and useful subsets of Salmonella; other probes are described which, while individually exhibiting rather poor exclusivity properties, are nevertheless valuable components of probe sets”which, when combined in an appropriate assay system, exhibit desirable overall performance characteristics. In one of the novel assay formats described below (dual-specific, capture/detection oligos), the ideal requirement for 100% exclusivity of each probe may be relaxed without sacrificing overall exclusivity behavior of the probe set, if individual probes of the set have non-overlapping patterns of undesirable cross hybridization.
In addition, the probes of the invention hybridize to target regions which can be rendered * accessible to the probes under normal assay conditions.
Other features and advantages of the invention will be apparent from the following description of the preferred embodiments thereof, and from the claims.

Description of the Preferred Embodiments Preferred embodiments of the invention are now described, after first briefly describing the drawings. Drawing
Fig. 1 is a diagrammatic illustration of E. coli 23S rRNA.
Fig. 2 is a diagrammatic illustration of E. coli 16S rRNA.
Fig. 3 is the nucleotide sequence of the -1405-1597 region of Fig. 1, including the sequence -of certain relevant bacterial strains and probes corresponding to portions of that region. Top: Secondary structure of S. typimurium 23S rRNA through this target region. Bottom: Salmonella probes to this region are shown aligned below their target sequences in two Salmonella 23S rRNAs representing the two distinct sequence patterns so far observed through this region. The corresponding sequence from one significant “competitor” organism, an Enterobacter agglomerans isolate from peanut butter (Eaggl PB) also is shown. Position numbers correspond to the E. coli numbering system. Only those positions which are different from E. coli are shown. Symbols used are: (.) deletion with respect to other sequences in the alignment, (-) same nucleotide as appears in E. coli. Lower case “a”, or “g” letters indicate non-complementary bases, lower case “c” indicates a cytosine analog capable of accepting a biotin label, and lower case “t” indicates a thymine positioned 5′ from a “c” in order to enable later addition of the “c”. Fig. 4 is the nucleotide sequence of the
-1700-1760 region of Fig. 1, including the sequences of certain relevant bacterial strains and probes corresponding to portions of that region. Top:

Secondary structure of E. coli 23S rRNA through this target region. Differences with the S. arizona and S. typhimurium (circled) sequences are indicated. Bottom: Salmonella probes to this region are shown aligned below. their target sequences in three Salmonella 23S r’RNAs representing the three sequence patterns so far observed through this region. Position numbering and symbols are as in Fig. 3.
Fig. 5 is the nucleotide sequence of the -430-510, region of Fig. 2, including the sequences of certain relevant bacterial strains corresponding to portions of that region. Top: Secondary structure of E. coli 16S rRNA through this target region. Differences with the S . arizona and Σ3. typhimurium (circled) sequences are indicated. Bottom: Salmonella probes to this region are shown aligned below their target sequences in four 23S rRNAs representing four of the sequence patterns so far observed through this ‘ region. – Position numbering and symbols are as in Fig. 3. Fig. 6 is the nucelotide sequence of the
-991-1045 region of Fig. 2, including the sequences of certain relevant bacterial strains corresponding to portions of that region. Top: Secondary structure of E. coli 16S rRNA through this target region. Bottom: Salmonella probes to this region are shown aligned below their target sequences. E. coli position numbering is used.
Fig. 7 is the nucleotide sequence of the -512-580 region of Fig. 1, including the sequences of certain relevant bacterial strains corresponding to portions of that region. Top: Secondary structure of E. coli 23S rRNA through a portion of this target region. Bottom: Salmonella probes to this region are

shown aligned below their target sequences. Numbering and symbols are as in Fig. 3.
Fig. 8 is an illustration of the various types of dual probe stategies which may be utilized to capture and detect 16S and/or 23S rRNA target molecules. Two Salmonella-specific (A & B) and one nonspecific (G = generic) probes are shown. Lines 1 and 7 are the two simplest examples of the dual specific format. Fig. 9 is an illustration of various alternative outcomes possible using either the dual –
(specific/generic), or dual specific capture/detection probe format. Referring to Fig. 8, strategy 1 corresponds to lines 2 or 8, strategy 3 corresponds to lines 1 or 7. Strategy 2 corresponds to the concept of adding multiple Salmonella-specific capture probes to a “set” in order to achieve the required inclusivity.
Fig. 10 is a tabulation of representative dot blot hybridization results- which demonstrates the exclusivity behavior of certain of the probes described herein.
Probe Development Strategy
The first step in the development of probes of the invention is to identify regions of 16S and 23S rRNA which potentially can serve as target sites for
Salmonella-specific nucleic acid probes. As a practical matter, it is difficult to predict, a priori, which non-SaImone11a organisms might be present in any test sample. Because of the large number of such potential non-Salmonella bacteria, demonstrating exclusivity for any given probe sequence is extremely difficult and laborious. However, a more rigorous criterion can be adopted which obviates the need to know, during initial stages of research and development, what non-Salmonella

bacteria might be present in all test samples that ultimately will be screened using the probe. This entails a knowledge of the phylogenetic relationships among Salmonella and between Salmonella and other groups of bacteria. Specifically, it is taken as an operating hypothesis that the exclusivity criterion may be satisfied by determining that a particular target region in Salmonella rRNA is sufficiently different from the homologous region in the rRNA of representative close evolutionary relatives of Salmonella that the Salmonella and relatives can be distinguished by hybridization using a probe specific to the Salmonella sequence. As a general rule then, based on phylogenetic principles, the rRNA sequences of more distantly related organisms, even though their actual identity is not necessarily known, can be predicted to be at least as different, in a particular region of sequence, than the aforementioned close evolutionary relative of Salmonella.
Although this principle has been adequately demonstrated over spans of fairly large evolutionary distance (e.g. inter-phylum level), it has not been demonstrated over the close distances under investigation here. In fact, we have found that while, on average, the principle holds quite well for the Salmonella and close relatives, it also is observed that instances of random sequence variation in the target regions occasionally and unpredictably violate the principle. Therefore, experimental testing of probes against large panels of representative Salmonella and non-Salmonella bacteria must remain the final criterion of probe performance.
As.our first step in identifying regions of Salmonella rRNA which might be useful as target sites

for nucleic acid hybridization probes, we have determined nearly complete nucleotide sequences of both the 16S and 23S rRNAs from two species of Salmonella, S. typhimurium and S. arizona. These were selected as representatives of two of major Salmonella DNA homology groups, and thus are representative of the evolutionary breadth of genus Salmonella. (Six such groups have been defined altogether, but four are comprised of small collections of “atypical” Salmonella. ) Nucleotide sequences of various portions of the rRNAs were determined by standard laboratory protocols either by cloning (Maniatis et al. 1982, Molecular Cloning: A laboratory manual) and sequencing (Maxa & Gilbert, 1977, Proceedings of the National Academy of Science. USA 74: 560-564, Sanger et al. 1977, Proceedings of the National Academy of Science. USA 74: 5463-5467) the genes which specify the rRNAs, and/or by direct sequencing of the -rRNAs themselves using reverse transcriptase (Lane et al. 1985, Proceedings of the National Academy of Science. USA 82: 6955-6959). The derived nucleotide sequences were compared to one another and to other available rRNA nucleotide sequences, in particular, to those of the closely related enteric bacterium Escherichia coli. A number of regions of sequence were discovered that exhibit potentially useful exclusivity characteristics with respect to the E___ coli rRNA sequences (i.e., contain Salmonella-specific sequences) . These are disclosed below. As discussed above, this preliminary analysis provides only a demonstration of feasibility. Further experimental testing of each nucleic acid probe is required to rigorously demonstrate the desirable

characteristics discussed above, namely: 1) adequate exclusivity as to most or all closely related organisms, 2) useful inclusivity patterns with respect to Salmonella, and 3) accessibility of the target regions under various assay conditions that might actually be employed. Because of the extremely large number of organisms potentially relevant to defining exclusivity (presently ca. 22 enteric genera, comprised of some 69 species and 29 unspeciated “biogroups”, Farmer et al. 1985, Journal of Clinical Microbiology 21: 46-76) and inclusivity (on the order of 2000 species and serotypes of Salmonella) characteristics of test probes, we have adopted the herein described interactive strategy with respect to testing and refinement of potential probes. The first generation probes are designed based on the principle of maximizing utilization of the observed nucleotide sequence variation in the target regions of Salmonella and non-Salmone11a bacteria. There is then carried out preliminary testing of the inclusivity and exclusivity properties of the first generation probes by “dot blot” analysis. Dot blot analysis can be performed in many different ways, but generally involves immobilizing a nucleic acid or a population of nucleic acids on a filte’r (e.g., nitrocellulose, nylon, or other derivatized membranes which are commercially available and useful for this purpose) . RNA can easily be so immobilized and then probed under, any of a variety of nucleic acid hybridization conditions (i.e., stringencies), for nucleotide sequences of interest. Techniques are also available in which RNA present in crude (unpurified) cell lysates can be immobilized without having to first purify the nucleic acid in question. This latter

approach significantly decreases the amount of effort required to screen for particular nucleotide sequences which may be present in the nucleic acids of any particular organism and, moreover, is amenable to the mass screening of large numbers of organisms. It, therefore, is the method of choice for testing the exclusivity and inclusivity properties of potential nucleic acid hybridization probes versus large numbers of organisms.
A list of non-Salmonella, enteric bacteria- which exemplify the type of bacteria that may be present in potentially Salmonella-containing samples is given in Table 1. These also represent many of the genera most closely related to Salmonella. As discussed above, a probe which demonstrates good exclusivity characteristics to such a broad representation of enteric Salmonella relatives can reasonably be predicted to behave-similarly to a much broader list of enteric organsi s than actually tested. . –
Table 1
Partial Listing of Non-Salmonella Enteric Bacteria Used in Screening Potential Probes
Escherichia coli Klebsiella ozaenae Enterobacter cloacae Klebsiella planticola Enterobacter aqqlomerans Klebsiella terrigena Enterobacter qerqoviae Providencia rettqeri Enterobacter aerogenes Proteus mirablis Enterobacter amniqenus Pseudo onas aeruqinosa Enterobacter intermedium Serratia odorifera Seratia licruefaciens Serratia marcescens . Shigella flexneri Shigella sonneii

Shigella boydii
Hafnia alvei Shigella boydii C-13 Klebsiella pneu oniae Shigella dysenteriae Morganella oxytoca Yersinia enterocolitica Proteus vulgaris Alteromonas putrefaciens

An analogous listing, comprised of Salmonella bacteria for which it is highly desirable that any Salmonella-specific probe be inclusive, would be very much longer than the “exclusivity panel” listing given in Table 1. Although DNA/DNA hybridization data suggest the existence a number of intra-genic groupings of Salmonella species and serotypes, many strains, particularly newly described ones, cannot be assigned with certainty to one of these groupings without resorting to DNA/DNA hybridization analysis. Our
Salmonella reference collection presently contains some 345 strains, representing all major and minor phylogenetic, biochemical, and serological groupings as well as a number of taxono ically undefined Salmonella. Inclusivity behavior of all potentially useful probes (or sets of probes) is characterized with respect to this collection.
The next step in probe design is sequence analysis of undesirable (false) positives and missed Salmonella (false negatives). The inclusivity and exclusivity information gathered from initial dot blot screenings of each probe sometimes identifies Salmonella strains to which the test probe hybridizes only weakly or not at all, and non-Salmonella strains to which it does hybridize. Rather than randomly modifying and retesting new versions of a given probe, a more informative approach has been adopted in which the relevant nucleotide sequence underlying the undesirable hybridization behavior in the organisms in question is determined. For this purpose, a reverse transcriptase sequencing strategy (Lane et al., 1985; Qu et al. , 1983, Nucleic Acids Research II: 5903-5920) is employed, which makes use of sequencing primers which have been

specifically designed to provide direct access to the rRNA regions of interest.
The next step is the refinement of probe geometries and retesting. Using the information gathered in the sequencing analysis above, new probes of altered geometries with respect to the target region (e.g., complementary to slightly different nucleotide sequences within the target region) , and/or altered nucleotide sequence (but targeted at the same target sequences, for instance), are designed and synthesized. These are then retested either by the dot blot procedure described above and/or by various other means such as one of the solution hybridization assays described below. Strict complementarity between the probe sequence and the target sequence is not necessarily the primary criterion for probe design. More important are satisfactory inclusivity and exclusivity properties.
Several other considerations also affect optimal design characteristics of a probe sequence. The first is’ consideration of the geometry of the probe with respect to itself. We have found that potentially useful target regions of the 16S and 23S rRNAs often are located in regions that exhibit substantial potential for self complementarity. Therefore, probes to these regions can also exhibit self complementarity. Because potential interactions between -the probe and target sequences are governed by the same types of interactions that govern the intramolecular annealing of the target or probe sequences to themselves, it is possible, particularly under solution hybridization conditions, that self-complementary probes can render themselves inaccessible for hybridization to their target sequences either by intra- or inter-molecular probe/probe

interactions. Thus, one aspect of probe design is to minimize such self-complementarity. This often necessitates making a compromise between maximum utilization of Salmonella-specific sequences and acceptable probe geometry.
An additional consideration in probe design arises with respect to the inclusivity criterion. The preferred probe will be one which, while displaying appropriate exclusivity behavior, also can hybridize to the rRNA(s) of all desired Salmonella bacteria. Because the genus Salmonella itself is comprised of bacteria which exhibit significant phenotypic and genetic (including, as disclosed below, rRNA diversity), it may not be possible to design (or discover) such an “ideal” probe. In practice, rather than demanding a “universal” Salmonella probe, a set of Salmonella-specific probes is sought, each of which exhibits appropriate exclusivity, and some useful level of inclusivity”. In aggregate, the set of probes will detect most or all Salmonella and few or no non-Salmonella bacteria. In such a set, for example, one probe can detect all but one or a few important Salmonella strains, and another probe may hybridize with good exclusivity only to1 those few Salmonella strains missed by the first probe. Thus, although the probes disclosed below are characterized on an individual basis with respect to inclusivity characteristics, it must be borne in mind that the concept of “sets” of specific probes detailed above must also be considered in determining the importance of individual probes.
This set notion also extends to evaluation of the exclusivity behavior of individual probes. For example, in the dual-specific capture/detection format
-•

described below, undesirable hybridization to non-Salmonella bacteria by otherwise useful ptobes or probe sets can be reduced or abolished by manipulation of the composition of the probe set(s) and the assay strategy employed.
A corollary of the “set notion of genus-level, Salmonella-specific probes is that certain aspects of the design of individual probes may reflect the requirement that their behavior be compatible, under particular assay conditions, with the “behavior” of- other probes in the set. An additional set of constraints on probe design are created where the probes are to be used in a solution hybridization format. For a variety of applications, solution hybridization formats can be the preferred choice of assay design. Potential advantages of solution hybridization assays include: a) enhanced kinetic properties of hybridization with respect to solid phase hybridizations (e.g., dot blot analyses, as outlined above), b) potentially enhanced background reduction characteristics of the assay (detection) system, and c) enhanced end-user “friendliness” of the assay system test.
Solution hybridization assays raise the issue of accessability of the target region to probes of various geometries. The strength of probe/target region interactions in solution hybridization can be controlled, to a certain extent, by varying parameters such as probe length, extent of complementarity to the -target region, self-complementarity, positioning of the target-sequence-complementary positions within the probe, incorporation of novel (e.g., derivatized) nucleotides, incorporation of various non-standard (i.e., non-Watson/Crick type) base pairings between the
v..

probe and target sequence (e.g., guanosine-uridine, adenosine-guanosine, or inosine-cytosine base pairs), etc.
” The strength of particular probe/target interactions can also be influenced by assay conditions. For example, in addition to those assay parameters mentioned above, selective deproteinization of the rRNA target, selective ribonuclease treatment of the rRNA target, selective use of second-site (not necessarily Salmonella-specific) probes to alleviate intramolecular target/target interactions and/or to’ accelerate probe/target interactions, and selective use of second-site probes in dual-probe capture/detection strategies (see below), can all improve assay results. In practice, the analysis of probe behavior under liquid hybridization conditions is not necessarily a discrete step, as implied here for clarity of presentation but, rather, is approached in an integrated fashion throughout the process of probe development.
The final step of probe design and analysis is testing of real (e.g., food/clinical) samples.
The probes of the invention can be used in a variety of formats, some of which are discussed below.
Antibody Capture Format S 1. Bacteria are lysed, in one embodiment, by treatment with low concentrations of base (e.g., NaOH) .
2. After lysis, the solution is neutralized to an approximate pH of 7 with buffer containing biotinylated probe or probes, and if necessary, a sodium C or potassium salt is added to approximately 0.6 Molar. In one embodiment, neutralization, salt addition, and probe addition are carried out concurrently with a

concentrated solution of sodium phosphate and probe.
3. Hybridization is allowed to occur.
4. In one embodiment, the sample is then treated with a high concentration of ribonuclease and
5 detergent at an elevated temperature, in order to degrade any probe/target complexed due to non-specific hybridization of the probe(s).
5. The solution containing the target-probe complex is now brought into contact with a surface .0 containing purified antibody (polyclonal or monoclonal) directed against DNA/RNA hybrids. This surface can be the inside or outside of a plastic tube, a microtiter plate well, a dipstick paddle, magnetic beads or polystyrene micro or macro beads. The target-probe 5 complex is allowed to bind to the antibody and the non-hybridized probe and non-Salmonella targets are washed away with the use of a buffered solution at room temperature.
6.’ A streptavidin-enzyme conjugate is added Q and, following incubation, excess conjugate is removed . by washing.
7. A chromogenic substrate for the enzyme then is added to the plastic surface, and a solution product is formed. 5 8. The color developed in the tube is a function of the amount of specific target captured and is quantified using a spectrophotometer or ELISA plate reader.
0. Streptavidin Capture Format
1. In one embodiment, bacteria are lysed, neutralized and hybridized with a biotinylated probe or probe set as described above. Alternatively, the

organisms’ cell wall may be weakened by enzymatic treatment and then lysed by the addition of a chaotropic salt (e.g. guanidiniurn thiocyanante) and probe or probes. 2. After hybridization, in one embodiment, the sample is then treated with a high concentration of ribonuclease and detergent at an elevated temperature, in order to destroy any probe/target complex which is due to non-specific hybridization of the probe(s). This step is not used with chaotrope lysis. 3. The solution containing the target-probe complex is now brought into contact with a surface containing bound streptavidin. As in the antibody capture method, this surface can be in a variety of configurations. The target-probe complex and free probe binds to the surface via the biotin-avidin bridge, and the non-hybridized nucleic acid is removed through a series of washes.
4. The bound target-probe complex (DNA/RNA hybrid) is differentiated from the surface bound excess free probe by the addition of specific antibody directed against DNA/RNA hybrids (polyclonal or monoclonal) . In one embodiment, this antibody is directly conjugated to an enzyme such as horseradish peroxidase or alkaline phosphatase. 5. If an antibody enzyme conjugate was used for binding to the DNA/RNA hybrids, substrate is then added and the bound enzyme-probe-target complex detected by the generation of colored product as described above.* An unconjugated primary antibody can be detected by the addition of a second antibody-enzyme conjugate with specificity against the first antibody (e.g., goat anti-mouse horseradish peroxidase conjugate for a monoclonal) and subsequent substrate addition and colored product generation.

Homopolymer Capture-Single Probe Format
1. Bacteria are lysed by either of the two lysis procedures detailed above.
2. Hybridization is carried out with probe or probes that have been enzymatically tailed with 20-200 dA residues at the 3′ end.
3. In one embodiment, a high concentration of RNAase and detergent is then added and allowed to digest any non-specifically hybridized target RNA.
4. The solution containing the target-probe complex is then brought into contact with a surface containing bound dT homopolymer 15-3000 nucleotides in length, under conditions that will allow hybridization between the dT and the dA “tail” of the probe, thus capturing the target-probe complex, as well as any remaining free probe.
5. Unhybridized nucleic acids and cellular debris are washed away, leaving the captured DNA/RNA complex attached via the dA-dT homopolymer. o 6. The bound target-probe complex (DNA/RNA hybrid) is differentiated from the surface-bound excess free probe by the addition of specific antibody directed against DNA/RNA hybrids (polyclonal or monoclonal). In one embodiment, this antibody is directly conjugated to 5 an enzyme such as horseradish peroxidase or alkaline phosphatase.
7. If an antibody enzyme conjugate was used for binding to the DNA/RNA hybrids, substrate is-^then added and the bound enzyme-probe-target complex detected 0 by the generation of colored product. An unconjugated primary antibody can be detected by the addition of a second antibody-enzyme conjugate with specificity

against the first antibody (e.g., goat anti-mouse horseradish peroxidase conjugate for a monoclonal) and substrate addition and colored product generation.
Homopolymer Capture – Dual Probe Format
1. Bacteria are lysed by either of the two lysis procedures detailed above.
2. Hybridization is carried out with 2 different probes, at least one of which, but not necessarily both of which, should preferentially anneal Salmonella target molecules. The capture probe or probes are enzymatically tailed with 20-200 dA residues at the 3′ end, and the reporter probes (oligomeric or polymeric DNA or RNA) are labeled either chemically or enzymatically with biotin.
3. The solution containing the target-probe complex is then brought into contact with a surface containing bound dT homopolymer 15-3000 nucleotides in length, under conditions that will allow hybridization between the dT and the dA “tail” of the probe, thus capturing the target-probe complex, as well as any remaining free capture probe.
4. Unhybridized nucleic acids and cellular debris are washed away, leaving the captured DNA/RNA complex attached via the dA-dT homopolymer.
5. The bound biotinylated reporter probe is detected by the addition of a streptavidin-enzyme complex, incubation to allow specific binding, washing to remove non-bound complex, addition of substrate and subsequent color development, as described in the antibody capture section above.
Distinct consequences may derive from different versions of the dual probe format just described

depending upon whether and how Salmonella-specific and non-specific probes are employed in the assay. Some of the possible variations are illustrated in Fig. 8, which emphasizes that both the 16S and 23S rRNAs (individually or together) can be subjected to dual probe (specific capture/generic detection) or dual specific
(capture/detection) strategies. The fundamental differences between the illustrated combinations derive from the alternative use of specific/generic or specific/specific combinations of capture/detection- probes. A consideration of the simplest case is illustrative’. Compare, for example lines 1 and 2 in Fig. 8. Line 1 illustrates a specific/specific dual probe assay scheme; line 2 illustrates a specific/generic dual probe scheme. Some of the hypothetical outcomes possible using these alternative strategies is shown in Fig. 9. The illustrated outcomes were arbitrarily chosen to reflect a near-random distribution of “hybridization positives and negatives for the hypothetical Salmonella probes A and B. In actuality, the relevant distribution for many of the Salmonella-specific probes described herein is far from random; Probe G illustrates a non-specific (i.e., G = generic) detection probe which will hybridize, under normal assay conditions, to any 16S or 23S rRNA target molecule (depending upon the specificity of the Generic probe, i.e., for 16S or 23S) .
Outcome 1 is based on using a single specific (capture) probe (A) and a generic detection probe (G). In essence, the outcome is defined by the inclusivity and exclusivity properties of probe A. Probe G detects everything that probe A captures.
Outcome 2 is an extension of strategy 1, and is

based on the additivity of inclusivity and exlusivity properties associated with specific capture probes A and B. Note that inclusivity in case 2 is improved over that in 1, but exclusivity is worsened. The outcome of strategy 3 (the dual specific oligo format) is conceptually different from that outlined for strategies 1 or 2. Rather than adding the inclusivity and exclusivity sets associated with probes A and B, only those organisms to which both A and B hybridize are included as positives in the dual specific oligo format. For example, the target molecule of organism N7 is captured by probe A but not detected by probe B. Conversely, the target molecule of organism N8 would be detected by probe B but, since it is not captured by A, is not available to be detected.
Strategy 3 would appear in theory to be less useful than the first two because the inclusivity and exclusivity profiles exhibit equal and offsetting “tradeoffs.” However, based on our observations on the patterns of nucleotide sequence variation in the 16S and 23S rRNAs of various enteric bacteria, (including Salmonella) and on the observed hybridization patterns of probes of various specificity to the different target sites, we conclude: (1) that different potential
Salmonella-specific target regions exhibit distinctly different and non-random patterns of sequence variation not only between Salmonella but also between Salmonella and various non-Salmonella bacteria. (2) that, ‘in particular, bacteria belonging to the genera Citrobacter and Enterobacter (to the exclusion of other enteric genera) are the most “problematic” with respect to hybridization to various

otherwise quite Salmonella-specific probes, and
(3) that, based on known information, including information of phylogenetic and/or biochemical character, the observed patterns of sequence variation are not fully predictable.
Probes
The probe selection strategy described above has yielded a number of probes useful in identifying Salmonella bacteria in samples. The first step in the probe selection process was to carry out nucleotide sequence analysis on the 16S and 23S rRNA’s of S. typhimurium and S. arizona. Comparison of these Salmonella sequences to non-Salmonella rRNA sequences (particularly E_;_ coli) identified sequences which meet the exclusivity criterion, i.e., they are essentially Salmonella specific, and are thus potential target regions to which probes could be directed. This analysis yielded five regions of rRNA (three in 23S and two in 16S) which contain useful or potentially useful Salmonella specific sequences. The positions of these regions, with respect to the positions of their structural and evolutionary homologs in E^ coli rRNAs, are indicated by circled regions in Figure 1 (23S rRNA) and Figure 2 (16S rRNA). Since homologous rRNAs vary somewhat in size from organism to organism and since, in every case, the exact 5′ nucleotide (by convention assigned as position number 1) of the Salmonella rRNAs have not been documented, use of the E^ coli numbering system, as is commonly done, provides the least ambiguous designation of regions of bacterial rRNA sequences..
Referring to Figs. 1 and 2, the definite

Salmonella-specific sequences are:
1) region -1405-1597; 23S rRNA;
2) region -1700-1760; 23S rRNA;
3) region -430-510; 16S rRNA. Still referring to Figs. 1 and 2, the probable
Salmonella-specific sequences are:
1) region -997-1045; 16S rRNA:
2) region -512-580; 23S rRNA;
These Salmonella-specific regions, and related probes, are described in more detail below. Liquid- hybridization assays using probes to these regions demonstrate good accessability of target sequences in these regions under both chaotropic and non chaotropic conditions. Generally, good sensitivity also is achieved. Not all probes shown in the Figures are discussed, however each probe is useful in the invention. Further, other probes may be readily constructed, using the guidelines discussed above. These examples are not limiting to this invention. 1) 23S rRNA region 1405-1597. This region is shown in Figure 3. Of the Salmonella strains whose 23S rRNA sequences have so far been inspected through this region, two structural patterns have been observed. One of these (designated pattern 1) is identical to that observed in E_^ coli, and is therefore, by definition, not a Salmonella-specific sequence. Nevertheless, probes complementary to this sequence pattern do hybridize to certain’ Salmonella rRNAs in a useful and important fashion, see below. The other (designated pattern 2) is identical to that originally determined to exist in the 23S rRNA of S_;_ typhimurium strain e23566 (shown in Figure 3). Pattern 2 contains two nucleotide insertions, in addition to the indicated nucleotide

sequence differences, with respect to the E^ coli (pattern 1) sequence through this region, and can be predicted to adopt an altered secondary structure compared to pattern 1-containing rRNAs. Referring to Fig. 3, a synthetic probe, designated “414”, has a sequence complementary to a portion of the S^ typhimurium 23S 1405-1597 region, also shown in Fig. 3. Probe 414 has been shown in dot blot analyses, using Salmonella and non-Salmonella strains, to exhibit good exlusivity characteristics, i.e., under conditions under which it hybridizes to pattern 2-containing rRNA, it fails to hybridize to the rRNA of E. coli or most of 64 other representative strains of the enteric bacterial species listed in Table 1. Extensive dot blot hybridization testing has revealed a number of Citrobacter and Enterobacter strains to which probe 414 will hybridize under assay or near assay conditions. (Exclusivity data is provided in Fig. 10) – The inclusivity characteristics of probe 414 were also found to be useful; the probe hybridized to the rRNA’s of 91% (311/343) of Salmonella strains tested, although only 66% (27/41) of the S^ arizona strains tested were detected by the 414 probe in dot blot hybridization assays; 94% (285/303) of non-S. arizona strains were detected by probe 414.
Variants of probe 414 can be designed in order to “match” the behavior characteristics of other probes of the probe sets in which probe 414 (or derivatives thereof) ultimately are utilized. Some of these are shown in Fig. 3.
Referring to Fig. 3, a synthetic probe, designated “791,” has a sequence complementary to a portion of the S^ arizona (and E^ coli) 23S 1405-1597

region, also shown in Fig. 3. Probe 791 has been shown in dot blot analysis, using the same Salmonella and non-Salmonella strains used above (and throughout this study), to exhibit inclusivity characteristics complementary to those exhibited by probe 414. That is, together the two probes hybridize (detect) the rRNAs of all Salmonella strains included in our test panels (i.e., are 100% inclusive for Salmonella, including a number of Salmonella belonging to a recently described new Salmonella group – group VI). The hybridization- profile of probe 791 is not strictly complementary to that of probe 414; while hybridizing to Salmonella strains to which probe 414 does not (as expected), it also hybridized quite strongly to many of the same bacterial strains as probe 414. This might be taken as evidence for sequence heterogeneity in the underlying rRNA populations of these bacterial strains – something which has not been previously observed. The poor exclusivity characteristics of probe 791 preclude its, use in most of the assay formats described above, with the exception of the dual specific capture/detection strategy which has been described above and is described in more detail below.
Variants of probe 791 can be designed to “match” the behavior characteristics of other probes of the probe sets in which probe 791 (or derivatives thereof) ultimately are utilized. Some of these are shown in Fig. 3.
Probes 414 and 791 have been tested to demonstrate the accessibility of their target regions, under a variety of solution hybridization assay formats as described above. Those tests have shown that the target regions are accessible to the probes in each case.

2) 23S rRNA region 1700-1760. This region is shown in Figure 4, and consists of “Salmonella-specific” sequences concentrated between nucleotide 1712 and 1746. Two predominant Salmonella-specific sequence 5 patterns have been observed in this region. Pattern 1 is defined by the sequence derived from S^ typhimurium strain e23566. Referring to Fig. 4, a probe designated “411”, complementary to a portion of the pattern 1 sequence of this region has been constructed. Probe 411 0 has been subjected to dot blot (inclusivity and exclusivity) and solution hybridization (accessibility) testing, all of which indicate the usefulness of the probe, and derivatives, variants, and fragments thereof. In dot blot tests, the 411 probe hybridized to 5 the rRNAs of a significant number of Salmonella strains (317/323=92%). Under these same conditions, the 411 probe does not hybridize to the rRNAs of a number of S. arizona strains tested (22 of the “misses” are to S. arizona strains) as predicted from the nucleotide o sequence analysis discussed above. The remaining “misses” are to a mixture of “atypical” Salmonella belonging, mostly, to DNA homology group V.
The exclusivity characteristics of probe 411 were also tested by dot blot analysis. Hybridization to 5 non-Salmonella bacteria was found to be restricted to a number of C^ freundii and C^ diversus strains, which variants of probe 411, were hybridized only weakly (Fig. 10).
Variants of probe 441 can be designed to 0 “match” the behavior characteristics of other probes of the probe sets in which probe 441 (or derivatives thereof) ultimately are utilized. Some of these are shown in Fig. 3.

The second sequence pattern observed in the 1700-1760 region (pattern 2) is defined by the sequence derived from ^ arizona strain RF908 (Fig. 4). It is sufficiently different from the pattern-1 sequence that RF908 is not detected by probe 411.
Referring to Fig. 4, synthetic probes, designated “690,” “799,” and “800,” have sequences complementary to various portions of the S_^ arizona RF908 23S 1700-1760 region, also shown in Fig. 4. In a manner analogous to that of probe 791, described above, all complement the inclusivity profile of probe 411 to this target tregion. That is, probe 411 plus any one of probes 690, 799, or 800, together are 100% inclusive for all Salmonella in our reference collection. The three • pattern 2-specific probes differ somewhat in their exclusivity behavior, with probe 800 exhibiting, by a slight margin, the best exclusivity profile at present. The combined exclusivity profiles of these various probe combinations can be seen in Fig. 9. Some cross hybridization to various C^. freundii and Q____ diversus strains is evident. For some Salmonella diagnostic assays, this pattern of non-Salmonella cross hybridization may be acceptable either because, for example, these particular non-Salmonella bacteria are not standardly encountered in the particular application; or because the speed, sensitivity, cost efficiency, and/or inclusivity of the test rendered it economically feasible to retest the few positives that might be obtained. Variants of these pattern-2 specific probes can be designed in order to “match” the behavior characteristics of other probes of the probe sets in which probe 411 (or derivatives thereof) ultimately are

utilized. In particular, two of the probe sets described above are amenable to the dual specific oligo capture/detection assay format (also described above). Referring to Fig. 10, using probe 411 plus probe 800, for example, as oligo adenosine-tailed, target-capture probes, and probe 414 plus probe 791. as, for example, biotinylated detection probes, a probe “set” is created which, in this dual specific format, collectively detects all Salmonella (100% inclusivity) and virtually no non-Salmonella bacteria. (The reverse would also work, i.e., 414 plus 791 capture, and 411 plus 800 detection, but probably would result in less efficient capture due to the fairly extensive cross hybridization of probe 791) . Some low level of hybridization to certain C. diversus strains may be expected, but, because both the capture and detection probe sets each hybridize only weakly to C^ diversus, the level of hybridization of the combined capture/detection probes to C^ diversus will be. acceptably small. A third Salmonella-specific sequence pattern, represented by S^ daressalaam, also is shown in Fig. 4. Probe 802 is complementary to this third pattern.
3) 16S rRNA region 430-510. This region is shown in Fig. 5, and consists of “Salmonella-specific” sequences concentrated between positions 455-477. Of the Salmonella strains whose 16S rRNA sequences have been obtained through this region, at least four different Salmonella-specific structural patterns have been observed (shown in Fig. 5). Pattern 1 was discovered initially from nucleotide sequence analysis of a cloned 16S rRNA gene from S^ typhimurium e23566. Subsequent sequence analysis of this target region in
*v

the 16S rRNA from this and other Salmonella indicates that pattern 1 is widely represented within the genus.
Referring to Fig. 5, a number of synthetic probes, designated “643,” “676,” “788,” “806,” and “807,” have sequences complementary to various portions of the pattern-1 containing 16S 430-510 region. All of these probes hybridize, with varying efficiencies, to the bulk of “typical” Salmonella (329/343 overall) but behave “spottily” against the “atypical” groups (groups IV, V, and VI) and fail to hybridize to 5/43 of our-S. arizona isolates as well.
In terms of exclusivity behavior, these pattern-1 probes cross hybridize to some, but not all, strains of Citrobacter freundii, C. diversus, Enterobacter cloacae, and _ sakazakii (Fig. 10).
Sequence analysis of this region from the 16S rRNA of these organisms indicates a closer evolutionary relationship between these species -and the ‘typical’ Salmonella than is presently generally acknowledged. T e second Salmonella-specific sequence discovered in this target region (pattern 2) was derived from the 16S rRNA (and a 16S rRNA gene) of S arizona (RF908) . Pattern 2 is sufficiently different in nucleotide sequence from pattern 1 that, under hybridization conditions (stringencies) where probes to pattern 1 exhibit acceptable exclusivity behavior, they do not hybridize to pattern 2-containing rRNAs. So far, one probe specific to this target region pattern has been constructed (number 678, probe and target sequence given in Fig. 5) and tested. It hybridizes only to certain S^ arizona strains. Probe 678 is extremely specific for its subset of S_^ arizona strains, hybridizing to no other Salmonella or non-Salmonella in our collection.

The third Salmonella-specific sequence discovered in this target region (pattern 3) was observed first in the 16S rRNA of S.^ weslaco. Subsequent sequence analysis of the 16S rRNAs of other Salmonella have revealed the presence of this pattern in a number of other strains including those of S_^ bongor and §___ riogrande. Pattern 3 is very closely related to pattern 1 in primary sequence, differing from the latter at only one position (see Fig. 5). At the hybridization stringincies commonly employed (i.e., those experimentally determined to provide acceptable exclusivity behavior) this one nucleotide difference is enough to significantly diminish (ca. 6-fold), but not abolish, cross hybridization between pattern 1 probes (e.g., 676) and pattern 3 target sequences (e.g., S. bongor) . At very high hybridization stringencies, or in formats employing a ribonuclense treatment step, this level of mismatching can easily be distinguished.
The fourth Salmonella-specific sequence pattern discovered in this target region (pattern 4) has been observed in one Salmonella species from our collection – a strain identified as CDC stk. N55 1925. By inference from the hybridization pattern of a probe specific for this pattern (probe 784, Fig. 5), it is a member of Salmonella group V. Probe 784 is quite specific for members of this group, exhibiting no significant hybridization to any other Salmonella or non-Salmonella bacteria in our collection. Thus, probe 784 like probe 678 described above, is highly exclusive and specific for a limited subgroup of Salmonella bacteria. Both probes can thus be used for subtyping Salmonella identified using other, broader specificity probes. This 16S rRNA target region, and the one

described immediately following (region 991-1045, Fig. 6) are the most highly variable which we have encountered in the Salmonella. Although this high level of sequence variability makes them potentially very useful for distinguishing various subgroups of
Salmonella, the sequences characteristic of the bulk of the “typical” Salmonella are too similar to those found in a number of Citrobacter and Enterobacter species to usefully circumscribe the typical Salmonella. Thus, the determination that sequence variation exists in a – particular region is not, in and of itself, sufficient to predict that an organism or group specific probe can be obtained.
4) 16S region 991-1045. Referring to Fig. 6, two synthetic probes, designated “754,” and “755,” have sequences complimentary to the” two main sequence patterns identified in 16S region 991-1045. Together, the two probes hybridize to most Salmonella in our collection but individually exhibit patterns of hybridization which reflect neither the established DNA homology groupings, nor the patterns exhibited by other sets of probes targeted at rRNA sequences. A number of Salmonella missed by both probes indicates that other, minor sequence patterns exist in this region among the Salmonella. Probes specific for these missed Salmonella could be designed.
Probe 754 individually hybridizes to many Salmonella, and only weakly to certain non-Salmone11a strains, so that it (or derivatives thereof) could be used in conjunction with other probes as part of a Salmonella-specific probe set. Probe 755 exhibits strong and extensive cross hybridization to representatives of numerous and quite distinct

non-Salmonella enteric bacteria. However, along with other of the non-exclusive “Salmonella” probes described herein, probe 755 could be useful as part of a broader specificity “Enteric-specific” probe set. 5) 23S rRNA region 512-560. This region is shown in Fig. 7, and consists of “Salmonella-specific” sequences concentrated between nucleotides 542-551. Analysis of this region has been especially difficult for two reasons. Some, but not all, Salmonella rRNA genes contain a large intron which interrupts the helical stem consisting of positions 532 to 560. This intron does not appear in the population of 23S rRNA molecules found in cells containing this gene structure. It would appear most likely that genes with this structure are inactive (data not shown) . Second, direct reverse transcriptase sequencing of the 23S rRNA through this region indicates that, in at least some Salmonella, there are point sequence heterogeneities in ” a number of positions located ‘within the 532-560 stem. Thus, cloning and sequencing multiple rRNA gene copies for certain Salmonella has been required to unambiguously determine nucleotide sequences through this region. In certain organisms, this region may be a recombinational “hot spot.” Referring to Fig. 7, two Salmonella-specific sequence patterns so far have been observed in this region. Pattern 1 is defined by the sequence derived from the rRNA of ______ typhimurium strain e23566. Pattern
2 was derived from a non-intron-containing gene of S_;_ arizona strain RF908. Both contain 2 “extra” nucleotides in the 532-560 stem, with respect to the E, coli sequence through this region and effectively lengthen the stem by one base pair. A set of probes,

designated 848, 849 and 892, complementary to portions ‘ of the pattern 1 sequence of this region have been constructed. Probes 848 and 849 have been tested in the dot blot format for their ability to hybridize Salmonella and non-Salmonella bacteria. Both probes hybridizes to 68% (233/343) of Salmonella bacteria tested. Since many of these “misses” are to multiple strains of the same Salmonella species, this percentage is deceptively low. Additionally, 31 of the misses are to S_^ arizona strains, so pattern 1-complementary probes to this region perform reasonably well versus non-arizona, Salmonella species.
Still referring to Fig. 7, another set of probes, designated 893, 894, and 895, complementary to portions of the pattern 2 sequence of this region have been constructed and are undergoing testing.
Additional sequence patterns through this region likely exist in various Salmonella. Hybridization results using probes to patterns 1 and 2 will pinpoint Salmonella where these additional sequence patterns may be found. Variants of the above-described, 512-560 region probes can be designed to “include” these Salmonella. Also, variants of the 512-560 region probes can be designed to “match” the behavior characteristics of other probes of the probe sets in which these probes (or derivatives thereof) ultimately are utilized.
Other embodiments are within the following claims:

Claims (14)

Claims

1. A nucleic acid fragment capable of hybridizing to rRNA of a Salmonella species and not capable of hybridizing to rRNA of Escherichia coli.

2. The nucleic acid fragment of claim 1, said fragment further being incapable of hybridizing to rRNA of Hafnia alvei, Klebsiella pneumoniae, Klebsilla oxytoca, Proteus vulgaris, Proteus mirabilis, Proteus morqanii, Proteus rettgeri, Pseudomonas aeruginosa, – Serratia odorifera, Serratia li uefaciens, Serratia marcescens, Shigella flexneri, Shigella sonneii, Shigella byoydii, Shigella dysenteriae, or Yersinia enterocolitica.

3. A set of nucleic acid fragments comprising a first nucleic acid fragment capable of hybridizing to- rRNA of a. first Salmonella species and not to rRNA of E___ coli, or rRNA of any bacteria of the genus Enterobacter, or to rRNA of a second Salmonella species and a second nucleic acid fragment capable of hybridizing to rRNA of said second Salmonella species.

4. The set of nucleic acid fragments of claim 3, said fragments together being capable of hybridizing to at least 80% of Salmonella species.

5. The nucleic acid fragment of claim 1, said fragments being homologous with at least 75% of a 10 nucleotide or larger region of the S^ typhimurium 23S rRNA subunit between nucleotides 721 and 757.

6. The nucleic acid fragment of claim 1, said fragments being homologous with at least 75% of a 10 nucleotide or larger region of the S__. typhimurium 23S rRNA subunit between nucleotides 1405 and 1597.

7. The nucleic acid fragment of claim 1, said fragment being homologous with at least 75% of a 10 nucleotide or larger region of the S_^ typhimurium 23S rRNA subunit between nucleotides 1700 and 1760.

8. The nucleic acid fragment of claim 1, said fragment being homologous with at least 75% of a 10 nucleotide or larger region of the S^ typhimurium 23S rRNA subunit between nucleotides 512 and 560.

9. The The nucleic acid fragment of claim 8, said fragment being homologous with at least 75% of a 10 nucleotide- or larger region of the S^ typhimurium 23S rRNA subunit between nucleotides 532 and 560.

10. The nucleic acid fragment of claim 1, said ‘fragment being homologous with at least 75% of a 10 nucleotide or larger region of the S_^ typhimurium 16S rRNA subunit between nucleotides 430 and 510.

11. The nucleic acid fragment of claim 10, said fragment being homologous with at least 75% of a 10 nucleotide or larger region of the ______ typhimurium 16S rRNA subunit between nucleotides 45*5 and 477.

12. The nucleic acid fragment of claim 1, said fragment being homologous with at least 75% of a 10 nucleotide or larger region of the S^ typhimurium 16S rRNA subunit between nucleotides 991 and 1045.

13. The nucleic acid fragment of claim 1 wherein said fragment is labeled.

14. A method of detecting the presence of 5 Salmonella bacteria in a sample comprising contacting the nucleic acid fragment of claim 1 with bacteria in said sample under conditions that allow said fragment to hybridize to rRNA of said Salmonella bacteria in said sample to form hybrid nucleic acid •*L complexes, and detecting said hybrid complexes as an indication of the presence of said Salmonella bacteria in said sample.

AU29328/89A
1987-12-01
1988-11-30
Detection of salmonella

Abandoned

AU2932889A
(en)

Applications Claiming Priority (2)

Application Number
Priority Date
Filing Date
Title

US12748487A

1987-12-01
1987-12-01

US127484

1987-12-01

Publications (1)

Publication Number
Publication Date

AU2932889A
true

AU2932889A
(en)

1989-07-05

Family
ID=22430379
Family Applications (1)

Application Number
Title
Priority Date
Filing Date

AU29328/89A
Abandoned

AU2932889A
(en)

1987-12-01
1988-11-30
Detection of salmonella

Country Status (7)

Country
Link

US
(2)

US5495008A
(en)

EP
(1)

EP0389564B1
(en)

JP
(1)

JP2795503B2
(en)

AT
(1)

ATE133454T1
(en)

AU
(1)

AU2932889A
(en)

DE
(1)

DE3854943T2
(en)

WO
(1)

WO1989005359A1
(en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

CA2025178A1
(en)

1989-10-02
1991-04-03
William G. Weisburg
Nucleic acid probes for the detection of lyme disease spirochetes

CA2025181A1
(en)

1989-10-12
1991-04-13
William G. Weisburg
Nucleic acid probes and methods for detecting fungi

CA2025180A1
(en)

1989-10-12
1991-04-13
William G. Weisburg
Nucleic acid probes and methods for detecting pathogenic candida yeasts

GB9020621D0
(en)

1990-09-21
1990-10-31
Imp Cancer Res Tech
Identification of organisms

GB2262987A
(en)

1990-09-21
1993-07-07
Imp Cancer Res Tech
Identification of organisms

WO1992015883A1
(en)

1991-03-08
1992-09-17
Amoco Corporation
Improved assays including colored organic compounds

US5635617A
(en)

1993-04-26
1997-06-03
University Of Victoria Innovation & Development Corp.
Methods and compositions comprising the agfA gene for detection of Salmonella

LT3828B
(en)

1993-11-10
1996-03-25
Fermentas Biotech Inst
Process for detecting salmonella bacteries and probe for the same

US5660981A
(en)

1994-06-06
1997-08-26
E. I. Du Pont De Nemours And Company
Selection of diagnostic genetic markers in microorganisms and use of a specific marker for detection of salmonella

CN1069925C
(en)

1995-03-10
2001-08-22
华南理工大学
Salmonella rDNA spacer nucleic acid molecular probe and its using method

US6458584B1
(en)

1996-12-23
2002-10-01
University Of Chicago
Customized oligonucleotide microchips that convert multiple genetic information to simple patterns, are portable and reusable

US6664045B1
(en)

1998-06-18
2003-12-16
Boston Probes, Inc.
PNA probes, probe sets, methods and kits pertaining to the detection of microorganisms

GB9827585D0
(en)

1998-12-15
1999-02-10
Celsis Int Plc
Assay method

US6821770B1
(en)

1999-05-03
2004-11-23
Gen-Probe Incorporated
Polynucleotide matrix-based method of identifying microorganisms

US7439016B1
(en)

2000-06-15
2008-10-21
Digene Corporation
Detection of nucleic acids by type-specific hybrid capture method

US20020090626A1
(en)

2000-09-26
2002-07-11
Hyldig-Nielsen Jens J.
Probes, probe sets, methods and kits pertaining to the detection, identification and/or enumeration of bacteria

EP1409738A4
(en)

2001-06-22
2005-03-30
Marshfield Clinic
Methods and oligonucleotides for the detection of salmonella sp.,e.coli o157:h7,and listeria monocytogenes

US6696254B2
(en)

2001-11-21
2004-02-24
Kimberly-Clark Worldwide, Inc.
Detection and identification of enteric bacteria

US20060240442A1
(en)

2005-04-20
2006-10-26
Vevea Dirk N
Methods and oligonucleotides for the detection of Salmonella SP., E coli 0157:H7, and Listeria monocytogenes

US20060246463A1
(en)

2005-04-20
2006-11-02
Vevea Dirk N
Methods and oligonucleotides for the detection of Salmonella SP., E coli 0157:H7, and Listeria monocytogenes

US8741565B2
(en)

2005-12-30
2014-06-03
Honeywell International Inc.
Oligonucleotide microarray for identification of pathogens

US8877436B2
(en)

2008-10-27
2014-11-04
Qiagen Gaithersburg, Inc.
Fast results hybrid capture assay on an automated platform

US11262979B2
(en)

2019-09-18
2022-03-01
Bank Of America Corporation
Machine learning webpage accessibility testing tool

Family Cites Families (16)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

US3755086A
(en)

1971-02-09
1973-08-28
Hoffmann La Roche
Diagnostic method utilizing synthetic deoxyrilionucleotide oligomer template

US4139346A
(en)

1977-11-28
1979-02-13
Enzo Bio Chem Incorporated
Nucleic acid and protein binding paper

US4302204A
(en)

1979-07-02
1981-11-24
The Board Of Trustees Of Leland Stanford Junior University
Transfer and detection of nucleic acids

US4228238A
(en)

1979-08-23
1980-10-14
The Allor Foundation
Method of laboratory testing in water-based culture media for zones of inhibition

US4359535A
(en)

1979-10-01
1982-11-16
George Pieczenik
Autonomously replicating DNA containing inserted DNA sequences

US4358535A
(en)

1980-12-08
1982-11-09
Board Of Regents Of The University Of Washington
Specific DNA probes in diagnostic microbiology

US4717653A
(en)

1981-09-25
1988-01-05
Webster John A Jr
Method for identifying and characterizing organisms

FI63596C
(en)

1981-10-16
1983-07-11
Orion Yhtymae Oy

MICROBIA DIAGNOSIS FOERFARANDE SOM GRUNDAR SIG PAO SKIKTSHYBRIDISERING AV NUCLEINSYROR OCH VID FOERFARANDET ANVAENDA KOMBINATIONER AV REAGENSER

EP0531798B2
(en)

1983-01-10
2003-12-17
Gen-Probe Incorporated
Method for detecting, identifying, and quantitating organisms and viruses

US4689295A
(en)

1983-01-20
1987-08-25
Integrated Genetics, Inc.
Test for Salmonella

GB8311905D0
(en)

1983-04-29
1983-06-02
Cox R A
Isolation and detection of nucleotide sequence

CA1231303A
(en)

1983-08-05
1988-01-12
Robert J. Carrico
Detection of bacteria by nucleic acid hybridization

EP0146039A3
(en)

1983-12-12
1986-08-27
Miles Inc.
Hybridization assay with immobilization of hybrids by antihybrid binding

EP0272009B2
(en)

1986-11-24
2007-10-03
Gen-Probe Incorporated
Nucleic acid probes for detection and/or quantitation of non-viral organisms

US5147778A
(en)

1987-12-01
1992-09-15
Amoco Corporation
Probes and methods for the detection of salmonella

ATE121793T1
(en)

1989-08-11
1995-05-15
Amoco Corp

DETECTION OF PNEUMOCYSTIS CARINII BY THE USE OF NUCLEIC ACID PROBE.

1988

1988-11-30
AU
AU29328/89A
patent/AU2932889A/en
not_active
Abandoned

1988-11-30
WO
PCT/US1988/004266
patent/WO1989005359A1/en
active
IP Right Grant

1988-11-30
EP
EP89901508A
patent/EP0389564B1/en
not_active
Expired – Lifetime

1988-11-30
JP
JP1501420A
patent/JP2795503B2/en
not_active
Expired – Lifetime

1988-11-30
DE
DE3854943T
patent/DE3854943T2/en
not_active
Expired – Lifetime

1988-11-30
AT
AT89901508T
patent/ATE133454T1/en
not_active
IP Right Cessation

1992

1992-04-17
US
US07/870,804
patent/US5495008A/en
not_active
Expired – Lifetime

1995

1995-06-06
US
US08/465,987
patent/US5792854A/en
not_active
Expired – Lifetime

Also Published As

Publication number
Publication date

WO1989005359A1
(en)

1989-06-15

ATE133454T1
(en)

1996-02-15

US5792854A
(en)

1998-08-11

DE3854943T2
(en)

1996-09-05

EP0389564A4
(en)

1993-03-17

EP0389564A1
(en)

1990-10-03

JP2795503B2
(en)

1998-09-10

JPH03503000A
(en)

1991-07-11

US5495008A
(en)

1996-02-27

DE3854943D1
(en)

1996-03-07

EP0389564B1
(en)

1996-01-24

Contact information